Abstract
The efficacy of labetalol, an alpha and beta receptor antagonist, was evaluated in 12 normotensive patients with stable angina pectoris in a single blind dose ranging study. After a two week period of placebo treatment, labetalol was given in doses of 100, 150, 200, and 300 mg twice daily, each for two weeks. Frequency of angina attacks decreased from 9.4 (SEM 2.3)/week in the control period to 7.3 (2.8), 5.2 (2.6), 3.8 (1.8), and 3.3 (1.9)/week in the four successive treatment periods. In the same periods the number of glyceryl trinitrate tablets consumed decreased from 7.0 (2.6)/week to 5.8 (3.3), 3.9 (2.9), 2.7 (1.8), and 2.6 (2.1)/week. Maximal symptom limited treadmill exercise tests were performed three and 12 hours after dosage at each dose. Exercise tolerance (expressed as seconds of the Bruce protocol) increased from 266 (44) with placebo to 306 (44), 369 (50), 396 (48), and 413 (51) in the four treatment periods. This improvement was accompanied by a significant blunting of the heart rate and blood pressure responses to exercise. Trough point exercise tolerance did not differ significantly from that at three hours after dosage. Thus labetalol is effective as an antianginal agent at doses of 150-300 mg twice daily and is well tolerated by the normotensive patient with angina.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Akhras F., Upward J., Stott R., Jackson G. Early exercise testing and coronary angiography after uncomplicated myocardial infarction. Br Med J (Clin Res Ed) 1982 May 1;284(6325):1293–1294. doi: 10.1136/bmj.284.6325.1293. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Charness M. E., Fishman J. A., Robertson D. Exacerbation of angina pectoris by prazosin. South Med J. 1979 Sep;72(9):1213–1214. doi: 10.1097/00007611-197909000-00040. [DOI] [PubMed] [Google Scholar]
- Frick M. H., Pörsti P. Combined alpha- and beta-adrenoceptor blockade with labetalol in hypertension. Br Med J. 1976 May 1;1(6017):1046–1048. doi: 10.1136/bmj.1.6017.1046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gagnon R. M., Morissette M., Présant S., Savard D., Lemire J. Hemodynamic and coronary effects of intravenous labetalol in coronary artery disease. Am J Cardiol. 1982 Apr 1;49(5):1267–1269. doi: 10.1016/0002-9149(82)90054-6. [DOI] [PubMed] [Google Scholar]
- Halprin S., Frishman W., Kirschner M., Strom J. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part II. Effects of oral labetalol in patients with both angina pectoris and hypertension: a preliminary experience. Am Heart J. 1980 Mar;99(3):388–396. doi: 10.1016/0002-8703(80)90354-3. [DOI] [PubMed] [Google Scholar]
- Hamer J., Sowton E. Effects of propranolol on exercise tolerance in angina pectoris. Am J Cardiol. 1966 Sep;18(3):354–360. doi: 10.1016/0002-9149(66)90053-1. [DOI] [PubMed] [Google Scholar]
- Jackson G., Harry J. D., Robinson C., Kitson D., Jewitt D. E. Comparison of atenolol with propranolol in the treatment of angina pectoris with special reference to once daily administration of atenolol. Br Heart J. 1978 Sep;40(9):998–1004. doi: 10.1136/hrt.40.9.998. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Joekes A. M., Thompson F. D. Acute haemodynamic effects of labetalol and its subsequent use of an oral hypotensive agent. Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):789–793. [PubMed] [Google Scholar]
- Richards D. A., Prichard B. N., Boakes A. J., Tuckman J., Knight E. J. Pharmacological basis for antihypertensive effects of intravenous labetalol. Br Heart J. 1977 Jan;39(1):99–106. doi: 10.1136/hrt.39.1.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Robinson B. F. Relation of heart rate and systolic blood pressure to the onset of pain in angina pectoris. Circulation. 1967 Jun;35(6):1073–1083. doi: 10.1161/01.cir.35.6.1073. [DOI] [PubMed] [Google Scholar]
- Silke B., Nelson G. I., Ahuja R. C., Taylor S. H. Comparative haemodynamic dose response effects of propranolol and labetalol in coronary heart disease. Br Heart J. 1982 Oct;48(4):364–371. doi: 10.1136/hrt.48.4.364. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Timmis A. D., Fowler M. B., Jaggarao N. S., Chamberlain D. A. Labetalol infusion for the treatment of hypertension in acute myocardial infarction. Eur Heart J. 1980 Dec;1(6):413–416. doi: 10.1093/oxfordjournals.eurheartj.a061141. [DOI] [PubMed] [Google Scholar]